Combination therapy with cerivastatin and gemfibrozil causing rhabdomyolysis: Is the interaction predictable? Reply

被引:0
|
作者
Alexandridis, G [1 ]
Elisaf, M [1 ]
机构
[1] Univ Ioannina, Dept Internal Med, Ioannina, Greece
来源
AMERICAN JOURNAL OF MEDICINE | 2001年 / 110卷 / 08期
关键词
D O I
10.1016/S0002-9343(01)00692-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:669 / 670
页数:2
相关论文
共 50 条
  • [41] Rhabdomyolisis associated with cerivastatin and cyclosporine combination therapy
    de Prado, IN
    López, MM
    Sánchez, SM
    Martínez, JM
    MEDICINA CLINICA, 2002, 118 (18): : 716 - 717
  • [42] Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
    Patel, Chinmay
    Thompson, Courtney
    Copley-Harris, Megan
    Hattab, Yousef
    CASE REPORTS IN MEDICINE, 2019, 2019
  • [43] Efficacy and safety of cerivastatin/fenofibrate combination therapy for hypercholesterolemia
    Farnier, M
    Megnien, S
    Turpin, G
    DIABETOLOGIA, 1999, 42 : A208 - A208
  • [44] Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: A case report
    Dalugama C.
    Pathirage M.
    Kularatne S.A.M.
    Journal of Medical Case Reports, 12 (1)
  • [45] Rhabdomyolysis following cerivastatin monotherapy - implications for therapy with HMG-CoA reductase inhibitors
    Sparing, R
    Sellhaus, B
    Noth, J
    Block, F
    NERVENARZT, 2003, 74 (02): : 167 - +
  • [47] Efficacy and safety of cerivastatin/bezafibrate combination therapy for dyslipidaemia.
    Esper, RJ
    Stein, E
    Lemme, L
    DIABETOLOGIA, 1999, 42 : A68 - A68
  • [48] Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide
    M. Niemi
    J. T. Backman
    M. Neuvonen
    P. J. Neuvonen
    Diabetologia, 2003, 46 : 347 - 351
  • [49] Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide
    Niemi, M
    Backman, JT
    Neuvonen, M
    Neuvonen, PJ
    DIABETOLOGIA, 2003, 46 (03) : 347 - 351
  • [50] Rhabdomyolysis due to warfarin and atorvastatin combination therapy in a patient with ischemic heart disease: (A drug interaction)
    Soliemanabad, Saeed Kargar
    Rasouli, Kimia
    Zakariaei, Zakaria
    Soleymani, Mostafa
    Aliabadi, Parastoo Karimi
    ANNALS OF MEDICINE AND SURGERY, 2022, 75